David E. Lazar Cyclacel Pharmaceuticals, Inc. (CYCC) insider trading activity

CYCC Quotes by TradingView

David E. Lazar is > 10% Shareholder of Cyclacel Pharmaceuticals, Inc.. Currently has a direct ownership of 155,838 shares of CYCC, which is worth approximately $1.45 Million. The most recent transaction as insider was on Jul 30, 2025, when has been sold 6,750 shares (Common Stock) at a price of $12.36 per share, resulting in proceeds of $83,430. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 156K
Infinity% 3M change
n/a 12M change
Total Value Held $1.45 Million

David E. Lazar Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 30 2025
SELL
Open market or private sale
$83,430 $12.36 p/Share
6,750 Reduced 4.15%
155,838 Common Stock
Feb 26 2025
SELL
Open market or private sale
$5,838,864 $0.03 p/Share
194,628,820 Reduced 100.0%
0 Common Stock
Feb 26 2025
BUY
Exercise of conversion of derivative security
-
194,628,820 Added 50.0%
194,628,820 Common Stock

Also insider at

TTNP
TITAN PHARMACEUTICALS INC Healthcare
Chief Executive Officer
MINM
MINIM, INC. Technology
Director
OPGN
OPGEN INC Healthcare
Chief Executive Officer
LQR
LQR House Inc.
President
DEL

David E. Lazar

> 10% Shareholder
Dubai, C0

Track Institutional and Insider Activities on CYCC

Follow Cyclacel Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CYCC shares.

Notify only if

Insider Trading

Get notified when an Cyclacel Pharmaceuticals, Inc. insider buys or sells CYCC shares.

Notify only if

News

Receive news related to Cyclacel Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CYCC